Arimidex
FDA Approves Kadcyla for Late-stage Breast Cancer »
"The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
HER2 is a protein involved in normal cell growth. It is foun"...
Read the FDA Approves Kadcyla for Late-stage Breast Cancer article »
Arimidex
Arimidex Consumer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
ANASTROZOLE - ORAL
(an-AS-TROE-zole)
COMMON BRAND NAME(S): Arimidex
USES: This medication is used to treat breast cancer in women who have gone through "the change of life" (menopause). Anastrozole works by lowering estrogen hormone levels to help shrink tumors and slow their growth.
HOW TO USE: Take this medication by mouth with or without food, usually once a day, or as directed by your doctor.
Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time each day.
Do not increase your dose or take this medication more often without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may be increased.
Since this drug can be absorbed through the skin, women who are pregnant or who may become pregnant should not handle or break the tablets of this medication.
Additional Arimidex Information
Arimidex - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Breast Cancer
Find support and advances in treatment.






